Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine modelBUI, Melanie R; HODSON, Victoria; DEGREGORI, James et al.Vaccine. 2010, Vol 28, Num 37, pp 6028-6035, issn 0264-410X, 8 p.Article

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteinsHALLER, Aurelia A; LAUER, Georg M; DUKE, Richard C et al.Vaccine. 2007, Vol 25, Num 8, pp 1452-1463, issn 0264-410X, 12 p.Article